Publications
40
Citations
806
Est. group size
~8
Recurring co-author estimate
Active years
37
Publishing since 1989
Typically publishes in teams of ~7 · 0% small-team papers (≤3 authors) · across 11 venues
- Development of Drug-resistant Cell Lines for Experimental Procedures
Journal of Visualized Experiments · 2025
- Correction to: Urinary extracellular vesicle‑derived miR‑126‑3p predicts lymph node invasion in patients with high‑risk prostate cancer
Medical Oncology · 2025
- Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancer
Medical Oncology · 2024
- Association of transitional gradient from clear cell to sarcomatoid renal cell carcinoma with macrophage/tumor cell crosstalk.
Journal of Clinical Oncology · 2024
- Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancer
Research Square · 2024
- Integration of Single-Cell RNA-Sequencing and Network Analysis to Investigate Mechanisms of Drug Resistance
Methods in molecular biology · 2023
- PD17-12 SPATIAL MOLECULAR IMAGING IN SARCOMATOID RENAL CELL CARCINOMA REVEALS CROSSTALK BETWEEN IMMUNE CELLS AND TUMOR CELLS
The Journal of Urology · 2023
- Supplementary Figures from Abituzumab Targeting of αV-Class Integrins Inhibits Prostate Cancer Progression
2023
- Supplementary Tables 1-6 from Single-Cell Transcriptomics Analysis Identifies Nuclear Protein 1 as a Regulator of Docetaxel Resistance in Prostate Cancer Cells
2023
- Supplementary Figures 1-6 from Single-Cell Transcriptomics Analysis Identifies Nuclear Protein 1 as a Regulator of Docetaxel Resistance in Prostate Cancer Cells
2023
- Data from Abituzumab Targeting of αV-Class Integrins Inhibits Prostate Cancer Progression
2023
- Supplementary Tables 1-6 from Single-Cell Transcriptomics Analysis Identifies Nuclear Protein 1 as a Regulator of Docetaxel Resistance in Prostate Cancer Cells
2023
- Supplementary Figures 1-6 from Single-Cell Transcriptomics Analysis Identifies Nuclear Protein 1 as a Regulator of Docetaxel Resistance in Prostate Cancer Cells
2023
- Abstract 4700: Spatial analysis of the immune microenvironment and tumor cell transition in sarcomatoid renal cell carcinoma
Cancer Research · 2023
- Supplementary Figures from Abituzumab Targeting of αV-Class Integrins Inhibits Prostate Cancer Progression
2023
- bioRxiv (Cold Spring Harbor Laboratory)×3
- Molecular Cancer Research×2
- Medical Oncology×2
- Cancer Research×2
- JCI Insight×1
- Xuhong Cao
Medicine · University of Michigan
- Arul Chinnaiyan
Medicine · University of Michigan
- Andi K. Cani
Medicine · University of Michigan
- Arul M. Chinnaiyan
Medicine · University of Michigan
- Lakshmi P. Kunju
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile